Pfizer Consumer Healthcare

Vanwall Road, Maidenhead, Berks, SL6 4UB
Telephone: +44(0)1628 692 002
Fax: +44(0)1628 414 728
Medical Information Direct Line: 0845 111 0151
Medical Information e-mail: carelineuk@pfizer.com
Customer Care direct line: 0845 111 0151
Medical Information Fax: +44(0)1628 414 728

Patient Information Leaflet last updated on the eMC: 12/10/2011
PIL Anadin Ultra Double Strength 400mg Capsules/Anadin LiquiFast 400mg Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 12/07/2011 and displayed until 12/10/2011
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
Updated on 02/02/2011 and displayed until 12/07/2011
Reasons for adding or updating:
  • Change to storage instructions
Updated on 11/10/2010 and displayed until 02/02/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/05/2010 and displayed until 11/10/2010
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Company name change or merger
  • Change to MA holder contact details
Updated on 19/02/2009 and displayed until 05/05/2010
Reasons for adding or updating:
  • Change to drug interactions
Updated on 12/12/2008 and displayed until 19/02/2009
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 12/06/2008 and displayed until 12/12/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 03/04/2008 and displayed until 12/06/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   ibuprofen